0001829126-21-009815.txt : 20210910 0001829126-21-009815.hdr.sgml : 20210910 20210909194643 ACCESSION NUMBER: 0001829126-21-009815 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20210908 ITEM INFORMATION: Changes in Control of Registrant ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20210910 DATE AS OF CHANGE: 20210909 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HEALTH REVENUE ASSURANCE HOLDINGS, INC. CENTRAL INDEX KEY: 0001514443 STANDARD INDUSTRIAL CLASSIFICATION: INSURANCE AGENTS BROKERS & SERVICES [6411] IRS NUMBER: 990363866 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 333-173039 FILM NUMBER: 211245552 BUSINESS ADDRESS: STREET 1: 5470 W. SPRUCE AVENUE , SUITE 102 CITY: FRESNO STATE: CA ZIP: 93722 BUSINESS PHONE: 559-271-5984 MAIL ADDRESS: STREET 1: 5470 W. SPRUCE AVENUE , SUITE 102 CITY: FRESNO STATE: CA ZIP: 93722 FORMER COMPANY: FORMER CONFORMED NAME: HEALTH REVENEUE ASSURANCE HOLDINGS, INC. DATE OF NAME CHANGE: 20120420 FORMER COMPANY: FORMER CONFORMED NAME: ANVEX INTERNATIONAL, INC. DATE OF NAME CHANGE: 20110303 8-K 1 healthrevenue_8k.htm 8-K
0001514443 false 0001514443 2021-09-08 2021-09-08 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

 

Date of Report (date of earliest event reported): September 8, 2021

 

HEALTH REVENUE ASSURANCE HOLDINGS, INC.

(Exact Name of Registrant as Specified in its Charter)

 

Nevada   333-173039   99-0363866
(State of incorporation)   (Commission File Number)   (IRS Employer Identification No.)

 

5470 W. Spruce Avenue, Suite 102

Fresno, CA

  93722
(Address of principal executive offices)   (Zip Code)

 

(559) 271-5984

(Registrant’s telephone number, including area code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

  

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Securities registered under Section 12(g) of the Exchange Act: None

    

Securities registered pursuant to Section 12(b) of the Act: None

 

Title of each class   Trading Symbol(s)   Name of each exchange on which
registered
N/A   N/A   N/A

 

 

 

 

 

 

Item 5.01 Changes in Control of Registrant.

 

On September 8, 2021, as a result of a private transactions, 10,000,000 shares of Series A-1 Preferred Stock, $0.001 par value per share (the “Shares”) of Health Revenue Assurance Holdings, Inc., a Nevada corporation (the “Company”), were transferred from Custodian Ventures, LLC to AmeriGuard Security Services, Inc. (the “Purchaser”). As a result, the Purchaser became holders of approximately 91% of the voting rights of the issued and outstanding share capital of the Company on a fully-diluted basis of the Company, and became the controlling shareholder. The consideration paid for the Shares was $450,000. The source of the cash consideration for the Shares was personal funds of the Purchaser. In connection with the transaction, David Lazar released the Company from all debts owed to him and/or Custodian Ventures, LLC.

 

Other than as described below, there are no arrangements or understandings among both the former and new control persons and their associates with respect to the election of directors of the Company or other matters. The information set forth in Item 5.02 of this Form 8-K is incorporated by reference into this Item 5.01.

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

On September 8, 2021, the existing director and officer resigned immediately. Accordingly, David Lazar, serving as a director and an officer, ceased to be the Company’s Chief Executive Officer, Chief Financial Officer, President, Treasurer, Secretary and a Director. At the effective date of the transfer, Lawrence Garcia consented to act as the new Chief Executive Officer, Chief Financial Officer, President, Treasurer, Secretary and a Director of the Company,

 

Lawrence Garcia, Chairman/CEO – From January 2002 to the present, Mr. Garcia has acted as Owner/Operator/Qualified Manager of AmeriGuard Security Services, Inc – Fresno, CA. It is licensed by the state of California Bureau of Security and Investigative Services (BSIS). In Charge of all decision making, managing and strategic planning for the entire company. Responsible for Sales & Marketing for all new and existing contracts. Contract manager at multiple facilities throughout U.S. Liaison between employees and management. Developed company in 10+ years from a 30+ employee local guard company to in excess of 500+ employees with operations throughout the United States. Fully qualified security officer, Guard Card, Firearm Permit, Baton Permit, Chemical Mace, First Aid/CPR, EMT, PC8-32, Level 3 Post Certificate, Search and Seizure Qualifications, basic laws to arrest, Concealed Weapons Permit and holder of Federal Firearms License (FFL). Diversified the business to include Alarm System installations (AmeriGuard Security Systems) and a Security Officer Training Academy (The Training Point).

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits.

 

99.1 STOCK PURCHASE AGREEMENT, dated September 8, 2021, by and between Custodian Ventures,. LLC and AmeriGuard Security Services, Inc.
99.2 DIRECTORS RESOLUTIONS, dated September 8, 2021.

   

 2 

 

  

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

September 9, 2021

 

HEALTH REVENUE ASSURANCE HOLDINGS, INC.  
     
  /s/ Lawrence Garcia  
By: Lawrence Garcia  
Title: CEO  

 

 3 

 

EX-99.1 2 healthrevenue_ex99-1.htm EXHIBIT 99.1

 

Exhibit 99.1

 

STOCK PURCHASE AGREEMENT

 

THIS STOCK PURCHASE AGREEMENT, effective as of the September 9, 2021 (the “Effective Date”) by and between Custodian Ventures LLC, a Wyoming limited liability company (“Seller”) and AmeriGuard Security Services, Inc. (“Buyer”).

 

WHEREAS, Seller owns 10,000,000 shares of Series A-1 Preferred Stock, par value $.001 per share, (collectively, the “Shares”) of HEALTH REVENUE ASSURANCE HOLDINGS, INC., a Nevada corporation (the “Company”). This Agreement provides for the acquisition of the Shares by Buyer for a total purchase price of Four Hundred Fifty Thousand U.S. Dollars ($450,000) (the “Purchase Price”) on the terms and conditions set forth below.

 

NOW, THEREFORE, on the stated premises and for and in consideration of the mutual covenants and agreements hereinafter set forth and the mutual benefits to the parties to be derived therefrom, it is hereby agreed as follows:

 

ARTICLE I

SALE AND PURCHASE OF THE SHARES

 

Section 1.1 Closing. The purchase of the Shares shall be consummated at a closing (“Closing”) to take place at 1:00 o’clock p.m., at the offices of Matthew McMurdo, Esq. 1185 Avenue of the Americas, 3rd Floor New York, New York 10036 on or before September 8, 2021 unless extended by agreement of the parties hereto (the “Closing Date”).

 

Section 1.2 Sale and Purchase. Subject to the terms and conditions hereof, at the Closing, Seller agrees to sell and deliver to Buyer, and Buyer agrees to purchase from Seller, the Shares.

 

Section 1.3 Purchase Price. The Purchase Price for the Shares shall be paid directly to Seller on or before the Closing Date, by Buyer to Seller, by wire transfer or other form of immediately available good funds against delivery of the Shares in transferable form from Seller to Buyer. Any portion of the Purchase Price held by the Escrow Agent as of the Closing Date shall be released by the Escrow Agent to Seller at the Closing upon delivery of irrevocable instructions from Buyer to Escrow Agent.

 

Section 1.4 Payment. Buyer shall apply such portion of the Purchase Price to the third-party accounts payable and accrued liabilities, so that the Company has zero third-party obligations at the Closing (the “Payables”).

 

Section 1.5 Waiver. Buyer shall waive any and all loans payable to it or to David Lazar at the Closing. (the “Waiver”).

 

ARTICLE II

REPRESENTATIONS AND WARRANTIES OF SELLER

 

As an inducement to and to obtain the reliance of Buyer, Seller represents and warrants to Buyer that each of the following are true, correct, and complete as of the Effective Date and will be correct and complete as of the Closing. All references in this Agreement to “knowledge of the Seller” shall mean the actual knowledge, after reasonable investigation, of the Seller and its sole manager, David Lazar. The Seller has no officers or any member or manager other than David Lazar.

 

Section 2.1 No Conflict, Authority. The execution of this Agreement and the consummation of the transactions contemplated by this Agreement will not result in the material breach of any term or provision of, or constitute an event of default under, any material debt instrument, which may include an indenture, mortgage, deed of trust or other contract, agreement or instrument to which Seller is a party or to which the Shares are subject. Seller has full power, authority and legal right and has taken all action required by law or otherwise to authorize the execution and delivery of this Agreement.

 

 

 

 

Section 2.2 Title to the Shares. Seller owns of record and beneficially the Shares of the Company, free and clear of all liens, encumbrances, pledges, claims, options, charges and assessments of any nature whatsoever, with full right and lawful authority to transfer the Shares to Buyer. No person has any preemptive rights or rights of first refusal with respect to any of the Shares. There exists no voting agreement, voting trust, or outstanding proxy with respect to any of the Shares. There are no outstanding rights, options, warrants, calls, commitments, or any other agreements of any character, whether oral or written, with respect to the Shares.

 

Section 2.3 Tax Matters. The Shares are not subject to any lien arising in connection with any failure or alleged failure to pay tax. There is no pending, threatened, or proposed audits, assessments or claims from any tax authority for deficiencies, penalties, or interest with respect to Seller that would affect the Shares.

 

Section 2.4 Due Diligence Materials Provided. Seller has provided Buyer with true and accurate copies of all corporate books and records relating to the Company in Seller’s possession or control, save and except those additional books and records. Seller does not have any actual knowledge of any liability or obligation of the Company other than is reflected in said books and records.

 

Section 2.5 Brokers and Finders. The Seller represents and warrants that Seller has made no agreements involving any fees of any type that relate to this Agreement and that would involve the Buyer, including but not limited to broker’s fee, finder’s fees or any similar compensation arrangement.

 

Section 2.6 Authorized Shares. As of the Closing (i) the total number of authorized shares of common stock of the Company shall be 500,000,000 par value $0.001 per share, and that the total number of shares of common stock of the Company issued and outstanding shall be 68,346,042 (ii) the total number of authorized shares of preferred stock of the Company shall be 10,000,000, par value $0.001 per share, and that the total number of shares of said preferred stock of the Company issued and outstanding shall be 10,000,000 of Series A-1.

 

Section 2.7 Litigation. To the knowledge of the Seller, (i) there is no claim, legal action, suit, arbitration, investigation or hearing, notice of claims or other legal, administrative or governmental proceedings pending or, to the knowledge of the Seller, threatened against the Seller or the Company; and (ii) there is no continuing order, injunction, or decree of any court, arbitrator, or governmental or administrative authority to which the Seller or the Company is a party or to which it or any of its assets is subject.

 

Section 2.8 Liabilities. To the knowledge of the Seller, there are no liabilities of the Company, other than the Payables and the liabilities to be waived in the Waiver. This assumption is based upon the proof of claims and the bar from claims proceedings connected to the Custodianship.

 

Section 2.9 Preferred Shares. Other than the Series A-1 Preferred Stock subject to the transaction hereunder, there are no other classes of Preferred stock outstanding. All other classes of Preferred Stock were converted into common stock with the consent of the courts of the State of Nevada.

 

ARTICLE III

REPRESENTATIONS AND WARRANTIES OF BUYER

 

As an inducement to and to obtain the reliance of Seller, Buyer represents and warrants to Seller that each of the following are true, correct, and complete as of the Effective Date and will be correct and complete as of the Closing. All references in this Agreement to “knowledge of the Buyer” shall mean the actual knowledge, after reasonable investigation.

 

Section 3.1 No Conflict, Authority. The execution of this Agreement and the consummation of the transactions contemplated by this Agreement will not result in the material breach of any term or provision of, or constitute an event of default under, any material debt instrument, which may include an indenture, mortgage, deed of trust or other contract, agreement or instrument to which Buyer is a party. Buyer has full power, authority and legal right and has taken all action required by law or otherwise to authorize the execution and delivery of this Agreement.

 

 2 

 

 

Section 3.2 Restricted Shares. Buyer acknowledges that the Shares purchased have not been registered under the Securities Act or any state securities laws, will be issued in reliance upon an exemption from the registration and prospectus delivery requirements of the Act which relate to private offerings, will be issued in reliance upon exemptions from the registration and prospectus delivery requirements of state securities laws which relate to private offerings and the Buyer must therefore bear the economic risk of such investment indefinitely unless a subsequent disposition thereof is registered under the Act and applicable state securities laws or is exempt therefrom. Buyer acknowledges that the shares shall bear restrictive legends.

 

Section 3.3 Buyer’s Sophistication. Buyer (i) acknowledges that the purchase of Shares involves a high degree of risk in that the Company has no current business operations or plans and may require substantial funds; (ii) an investment in the Company is highly speculative and only investors who can afford the loss of their entire investment should consider investing in the Company and the Shares; (iii) has such knowledge and experience in finance, securities, investments, including investment in non-listed and non-registered securities, and other business matters so as to be able to protect its interests in connection with this transaction; (iv) that the sale of the Shares to Buyer is not registered with the US Securities and Exchange Commission or with the securities administrator of any state; (v) that the Shares are being sold pursuant to an exemption from such registration requirements; and (vi) the Shares are “restricted securities” that will bear a restrictive legend prohibiting their further transfer without registration or any exemption therefrom.

 

Section 3.4 Brokers and Finders. The Buyer represents and warrants that he/she/it has made no agreements involving any fees of any type that relate to this Agreement and that would involve the Seller, including but not limited to broker’s fee, finder’s fees or any similar compensation arrangement.

 

Section 3.5 Due Diligence Materials Provided. Buyer acknowledges that Seller has provided Buyer provided Buyer with true and accurate copies of all corporate books and records relating to the Company in Seller’s possession or control. Buyer acknowledges that Seller has only recently become the controlling shareholder of the Company and has obtained control of the Company through court process which, by its nature, provides Seller with only very limited information regarding the Company, its history, its financial condition and any potential debts, obligations, liabilities or other claims. Buyer understands that there may be significant obligations, claims or other obligations against the Company of which the Seller is unaware that would make the Company unsuitable for the business operations therein contemplated by Buyer, and Buyer expressly assumes such risk.

 

ARTICLE IV

EXCHANGE PROCEDURE AND OTHER CONSIDERATION

 

Section 4.1 Seller’s Delivery. On the Closing Date, the Seller shall deliver the following to Buyer or the transfer agent, as applicable, conditioned upon (i) all of Buyer’s representations and warranties set forth in Article III, above, shall be true and correct as of the Closing, and (ii) Buyer’s performance of its delivery obligations in section 4.2, below:

 

(a)The Shares together with a stock power or other instruction required for the transfer of the Shares to Buyer. If necessary, after the sale closes the Seller shall also execute such other certificates or other documents reasonably necessary to transfer the Shares to Buyer. If the Shares are to be transferred electronically in book form, then irrevocable instructions from the Seller to the Escrow Agent and/or the Company’s transfer agent directing the transfer of the Shares to the Buyer.
(b)Written consent from the Company’s board of directors appointing Buyer’s designee to the board of directors, effective upon Closing.
(c)Written resignation from all members of the Company’s board of directors excepting only Buyer’s designee, effective upon Closing.
(d)A written resignation from all officers of the Company, effective upon Closing.
(e)A current list of shareholders.
(f)A written waiver and release from Seller in favor of the Company of any debt obligation owed to Seller, as described in the Waiver.
(g)A signed Bar from Claims order.
(h)EDGAR codes.

 

 3 

 

 

Section 4.2 Buyer’s Delivery. On the Closing Date, Buyer shall deliver the following to Seller, conditioned upon (i) all of Seller’s representations and warranties set forth in Article II, above, shall be true and correct as of the Closing, and (ii) Buyer’s performance of its delivery obligations in section 4.1, above:

 

(a)Purchase Price in immediately available funds.
(b)A written consent to serve on the Company’s board of directors by the Buyer’s nominee, effective upon Closing, including the nominee’s mailing address.
(c)A written consent from Buyer’s nominee to serve as the President and as other officers of the Company, effective upon Closing, including the nominee’s mailing address.
(d)A written consent from the Buyer’s nominee to the board of directors, acting in his or her capacity as the sole director of the Company, appointing Buyer’s nominee to serve as President and to other offices of the Company, effective upon Closing.

 

ARTICLE V

MISCELLANEOUS

 

Section 5.1 Notification of OTC Markets, FINRA and Nevada Secretary of State. Buyer and Seller, as applicable, shall take the following actions, except as expressly stated below:

 

(a)Notify OTC Markets or the SEC via EDGAR, of the new address for the Company, the new director(s) of the Company and the new officers of the Company, including its President. Buyer shall promptly pay any fees associated with this notice.
(b)Notify FINRA corporate actions office, if required by its rules and procedures, of the change in control of the Company, the new address and resident agent for the Company, the new director(s) of the Company and the new officers of the Company, including its President, and the new controlling shareholder(s) of the Company. Buyer shall promptly pay any fees associated with this notice.
(c)Notify the Nevada Secretary of State, by filing an annual list of officers and directors, when due, and by filing a change in resident agent notification, if applicable, of the address and resident agent for the Company, the new director(s) of the Company and the new officers of the Company, including its President. Buyer shall promptly pay any fees associated with these filings.
(d)Confirm to the other party hereto in writing via email, that the obligations pursuant to Sections 5.1(a), (b) and (c), above have been performed.
(e)Should Seller fail to perform according to this Section 5.1, Seller expressly authorizes Buyer to provide the notices and filings contemplated by this Section 5.1 and Buyer agrees to promptly reimburse Seller for all expenses related thereto, including filing fees and attorney’s fees actually incurred.

 

Section 5.2 Notices. Any notices or other communications required or permitted hereunder shall be sufficiently given if personally delivered to it or sent by overnight carrier or USPS via registered mail or certified mail, postage prepaid, addressed to the addresses set forth in this Agreement or such other addresses as shall be furnished in writing by any party in the manner for giving notices hereunder, and any such notice or communication shall be deemed to have been given as of the date so delivered, mailed or sent. Any party with a non-US address may be provided notice via email, which notice shall be effective when sent to the party or its representative.

 

Section 5.3 Attorneys’ Fees. Except as expressly provided herein, each party will be responsible for their own attorney’s fees.

 

Section 5.4 Confidentiality. Each party hereto agrees with the other party that, unless and until the transactions contemplated by this Agreement have been consummated, they and their representatives will hold in strict confidence (a) the existence and terms of this Agreement and the transactions contemplated hereby, and (b) all data and information obtained with respect to another party or any subsidiary thereof from any representative, officer, director or employee, or from any books or records or from personal inspection, of such other party, and shall not use such data or information or disclose the same to others, except: (i) to the extent such data is a matter of public knowledge or is required by law to be published; and (ii) to the extent that such data or information must be used or disclosed in order to consummate the transactions contemplated by this Agreement. In addition, no party shall issue any press release or other public announcement concerning this Agreement, its existence or the transactions contemplated by this Agreement, without the prior written approval of the remaining parties.

 

 4 

 

 

Section 5.5 Entire Agreement. This Agreement represents the entire agreement between the parties relating to the subject matter hereof. This Agreement alone fully and completely expresses the agreement of the parties relating to the subject matter hereof. There are no other courses of dealing, understanding, agreements, representations or warranties, written or oral, except as set forth herein. This Agreement may not be amended or modified, except by a written agreement signed by all parties hereto.

 

Section 5.6 Survival; Termination; Limitation of Seller’s Liability. The representations, warranties and covenants of the respective parties shall survive the Closing and the consummation of the transactions herein contemplated six (6) weeks after the Closing Date. In no instance shall the liability of Seller (including, without limitation its owners or managers) arising hereunder or by reason of or related to any of the transactions contemplated hereby exceed the amounts actually paid by Buyer to Seller under this Agreement.

 

Section 5.7 Counterparts. This Agreement may be executed in multiple counterparts, each of which shall be deemed an original and all of which taken together shall be but a single instrument.

 

Section 5.8 Amendment or Waiver. Every right and remedy provided herein shall be cumulative with every other right and remedy, whether conferred herein, at law, or in equity, and may be enforced concurrently herewith, and no waiver by any party of the performance of any obligation by the other shall be construed as a waiver of the same or any other default then, theretofore, or thereafter occurring or existing. At any time prior to the Closing, this Agreement may be amended by a writing signed by all parties hereto, with respect to any of the terms contained herein, and any term or condition of this Agreement may be waived or the time for performance hereof may be extended by a writing signed by the party or parties for whose benefit the provision is intended.

 

Section 5.9 Expenses. Each party herein shall bear all of their respective costs and expenses incurred in connection with the negotiation of this Agreement and in the consummation of the transactions provided for herein and the preparation thereof.

 

Section 5.10 Headings; Context. The headings of the sections and paragraphs contained in this Agreement are for convenience of reference only and do not form a part hereof and in no way modify, interpret or construe the meaning of this Agreement.

 

Section 5.11 Benefit. This Agreement shall be binding upon and shall inure only to the benefit of the parties hereto, and their permitted assigns hereunder. This Agreement shall not be assigned by any party without the prior written consent of the other party. This contract is between Seller and Buyer. No person or entity shall be deemed to be a third-party beneficiary of this Agreement.

 

Section 5.12 Severability. In the event that any particular provision or provisions of this Agreement or the other agreements contained herein shall for any reason hereafter be determined to be unenforceable, or in violation of any law, governmental order or regulation, such unenforceability or violation shall not affect the remaining provisions of such agreements, which shall continue in full force and effect and be binding upon the respective parties hereto.

 

Section 5.13 No Strict Construction. The language of this Agreement shall be construed as a whole, according to its fair meaning and intendment, and not strictly for or against either party hereto, regardless of who drafted or was principally responsible for drafting the Agreement or terms or conditions hereof.

 

Section 5.14 Execution Knowing and Voluntary. In executing this Agreement, the parties severally acknowledge and represent that each: (a) has fully and carefully read and considered this Agreement; and (b) has been or has had the opportunity to be fully apprized by its attorneys of the legal effect and meaning of this document and all terms and conditions hereof.

 

Section 5.15 Further Assurances, Cooperation. Each party shall, upon reasonable request by the other party, execute and deliver any additional documents necessary or desirable to complete sale contemplated by this agreement. The parties hereto agree to cooperate and use their respective best efforts to consummate the transactions contemplated by this agreement.

  

[remainder of this page intentionally blank, signature page to follow]

 

 5 

 

 

Section 5.16 Governing Law. This Agreement shall be construed (both as to validity and performance) and enforced in accordance with and governed by the laws of the state of Nevada applicable to agreements made and to be performed wholly within such jurisdiction and without regard to its conflicts of laws principles. Any dispute arising out of this Agreement shall be resolved in the state or federal courts sited in Clark County, Nevada to the exclusion of all other venues. The prevailing party in any such action shall be entitled to an award of costs and its reasonable attorney’s fees.

 

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed as of the date first above written.

 

Seller   Buyer
         
By: Custodian Ventures LLC.   By: AmeriGuard Security Services, Inc.
         
  /s/ David Lazar     /s/ Lawrence Garcia
Name:  David Lazar   Name:  Lawrence Garcia
Title: CEO   Title: Owner
                                                                 
Address of Seller for Notices:   Address of Buyer for Notices:
     
1185 Avenue of the Americas, 3rd Floor. New York,
New York 10036.
  email: lg@ameriguardsecurity.com
     
With a copy to (which shall not constitute notice):    
     
     
Email: David@activistinvestingllc.com    

  

 6 

 

EX-99.2 3 healthrevenue_ex99-2.htm EXHIBIT 99.2

 

Exhibit 99.2

 

DIRECTORS RESOLUTIONS
OF

HEALTH REVENUE ASSURANCE HOLDINGS, INC.
(the “Company”)

WHEREAS:

 

A.David Lazar has consented to step down as Chief Executive Officer, Chief Financial Officer, Treasurer, Secretary and as a Member of the Board of Directors of the Company.
  
B.Lawrence Garcia has consented to act as the new President, CEO, CFO, Treasurer, Secretary, and Chairman of the Board of Directors of the Company.

 

BE IT RESOLVED THAT:

 

C.David Lazar stepped down as Chief Executive Officer, Chief Financial Officer, Treasurer, Secretary and as a Member of the Board of Directors of the Company.

 

D.Lawrence Garcia act as the new President, CEO, CFO, Treasurer, Secretary, and Chairman of the Board of Directors of the Company.

 

Effective date: September 8, 2021

  

/s/ David Lazar  
David Lazar  
   
/s/ Lawrence Garcia  
Lawrence Garcia  

 

 

 

EX-101.SCH 4 hraa-20210908.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 5 hraa-20210908_lab.xml XBRL LABEL FILE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 6 hraa-20210908_pre.xml XBRL PRESENTATION FILE XML 7 healthrevenue_8k_htm.xml IDEA: XBRL DOCUMENT 0001514443 2021-09-08 2021-09-08 iso4217:USD shares iso4217:USD shares 0001514443 false 8-K 2021-09-08 HEALTH REVENUE ASSURANCE HOLDINGS, INC. NV 333-173039 99-0363866 5470 W. Spruce Avenue Suite 102 Fresno CA 93722 (559) 271-5984 false false false false false XML 8 R1.htm IDEA: XBRL DOCUMENT v3.21.2
Cover
Sep. 08, 2021
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Sep. 08, 2021
Entity File Number 333-173039
Entity Registrant Name HEALTH REVENUE ASSURANCE HOLDINGS, INC.
Entity Central Index Key 0001514443
Entity Tax Identification Number 99-0363866
Entity Incorporation, State or Country Code NV
Entity Address, Address Line One 5470 W. Spruce Avenue
Entity Address, Address Line Two Suite 102
Entity Address, City or Town Fresno
Entity Address, State or Province CA
Entity Address, Postal Zip Code 93722
City Area Code (559)
Local Phone Number 271-5984
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.2 html 1 96 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://ANVX.com/role/Cover Cover Cover 1 false false All Reports Book All Reports healthrevenue_8k.htm healthrevenue_ex99-1.htm healthrevenue_ex99-2.htm hraa-20210908.xsd hraa-20210908_lab.xml hraa-20210908_pre.xml http://xbrl.sec.gov/dei/2021 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "healthrevenue_8k.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "inline": { "local": [ "healthrevenue_8k.htm" ] }, "labelLink": { "local": [ "hraa-20210908_lab.xml" ] }, "presentationLink": { "local": [ "hraa-20210908_pre.xml" ] }, "schema": { "local": [ "hraa-20210908.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021_doc.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021_ref.xsd" ] } }, "elementCount": 59, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 96, "memberCustom": 0, "memberStandard": 0, "nsprefix": "hraa", "nsuri": "http://ANVX.com/20210908", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "healthrevenue_8k.htm", "contextRef": "From2021-09-08to2021-09-08", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "role": "http://ANVX.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "healthrevenue_8k.htm", "contextRef": "From2021-09-08to2021-09-08", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://ANVX.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://ANVX.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://ANVX.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://ANVX.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://ANVX.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://ANVX.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://ANVX.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://ANVX.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r9", "r11", "r12" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://ANVX.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://ANVX.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://ANVX.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://ANVX.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://ANVX.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://ANVX.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://ANVX.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://ANVX.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://ANVX.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://ANVX.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://ANVX.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://ANVX.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://ANVX.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://ANVX.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://ANVX.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://ANVX.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://ANVX.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://ANVX.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://ANVX.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://ANVX.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://ANVX.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://ANVX.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://ANVX.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://ANVX.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r17" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://ANVX.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://ANVX.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://ANVX.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://ANVX.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://ANVX.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://ANVX.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://ANVX.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://ANVX.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://ANVX.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://ANVX.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://ANVX.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://ANVX.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://ANVX.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://ANVX.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://ANVX.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://ANVX.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://ANVX.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://ANVX.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://ANVX.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://ANVX.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://ANVX.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://ANVX.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://ANVX.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://ANVX.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://ANVX.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://ANVX.com/role/Cover" ], "xbrltype": "booleanItemType" } }, "unitCount": 3 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23" }, "r10": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r11": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r12": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r13": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r14": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r15": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r16": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" }, "r17": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r18": { "Name": "Securities Act", "Number": "Section", "Publisher": "SEC", "Section": "12" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r6": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r7": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d" }, "r8": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r9": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310" } }, "version": "2.1" } ZIP 15 0001829126-21-009815-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001829126-21-009815-xbrl.zip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end